Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

NCT01392352 2020-02-13

HYPAZ

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT00775307 2019-09-24

Adjuvant Pazopanib in Stage I NSCLC

Phase 2/3 Completed

142 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01179269 2016-10-12

Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01027598 2016-01-29

Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

Phase 2 Completed

202 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01049776 2014-09-19

GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line

Phase 2 Terminated

32 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01060514 2013-10-30

Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer

Phase 1 Terminated

8 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Pazopanib in Molecularly Selected Patients With Advanced NSCLC

HYPAZ

Adjuvant Pazopanib in Stage I NSCLC

Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer

Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line

Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer